Revenue segments as reported by the company.

Pharmacy revenues

Premiums

Fees and other revenues

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Pharmacy and other service costs

Medical costs and other benefit expenses

Selling, general and administrative expenses

Amortization of acquired intangible assets

Special items

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cigna

Express Scripts is a company that provides integrated pharmacy benefit management services including network-pharmacy claims processing; home delivery pharmacy services; specialty pharmacy benefit management, through its subsidiary Accredo; benefit-design consultation; drug-utilization review; formulary management; and medical and drug data analysis services to manage drug plans for health plans, self-insured employers and government agencies (both as administrator of employee benefits and public assistance programs). Express Scripts also offers pharmacy benefit management services for workers' compensation insurance programs. The program is accredited by URAC, the nation's largest accrediting body for pharmacy benefit management companies. The company processes pharmaceutical claims for members through a network of retail pharmacies. Its own automated pharmacies dispense long-term, chronic medications-like those for diabetes or heart disease-directly to members by home delivery.

Express Scripts

The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cigna posts strong Q4 earnings, eyes growth in specialized services

Cigna delivered strong financial results in Q4 2022, with robust revenue growth and operational performance across key business segments.
While facing challenges such as margin pressures and potential disenrollment, Cigna is well-positioned to capitalize on growth opportunities in 2023.
Strategic partnerships, customer-focused strategies, and financial discipline underscore Cigna's commitment to sustainable growth and shareholder value creation.
Investments in innovation, care coordination, and market expansion signal a proactive approach to navigating industry dynamics and driving future success.

Cigna reports robust Q1 earnings, eyes growth amid challenges

Cigna's Q1 2023 showcased strong financials, growth in key segments, and increased outlook.
Challenges include economic softening impact and margin expectations for the year.
Opportunities lie in customer relationships, innovation, and market-specific strategies.
Overall, Cigna remains confident in delivering on its financial and growth targets.

Cigna reports robust Q2 results, eyes growth through innovation

Cigna's Q2 2023 performance was strong, with revenue growth, customer expansion, and technological advancements driving positive outcomes.
While facing challenges like disenrollment and risk adjustment payables, Cigna is leveraging strengths in technology and cross-selling for growth.
Opportunities lie in partnerships like VillageMD, continued innovation, and strategic bidding strategies for future growth.
Overall, Cigna remains confident in delivering on adjusted EPS outlook for 2023 and 2024, with a focus on innovation and growth.

Cigna surpasses Q3 expectations, eyes $28 EPS in 2024

Cigna's Q3 performance exceeded expectations, driven by strong revenue and EPS growth across key business segments.
Strategic focus on innovation, affordability, and client partnerships positions Cigna well for future growth and value creation.
Challenges in margin expectations and enrollment declines require proactive management and strategic decision-making.
Opportunities lie in continued growth projections, strategic investments, and enhancing healthcare affordability and accessibility.

Cigna reports robust Q4 performance, eyes growth amid strategic changes

Cigna Group's Q4 2023 Earnings Call highlighted strong financial performance, leadership changes, and strategic decisions. Analyst inquiries focused on growth drivers, market outlook, and internal healthcare spend management. The outlook for 2024 includes expectations of solid adjusted EPS, revenue growth, and operating cash flow.

Cigna surpasses Q1 expectations, eyes growth through AI and biosimilars

Cigna's Q1 performance exceeded expectations, driven by strong revenue and EPS figures.
Despite challenges like noncash losses and disruptions, Cigna's strategic strengths in AI, biosimilars, and value-based care position it well for growth.
Opportunities in AI-driven healthcare solutions, biosimilar expansions, and strategic M&A offer avenues for future growth.
Cigna's focus on precision care solutions and client outcomes showcases its commitment to innovation and efficiency.

Cigna (CI) posts robust Q2 results, eyes biosimilar growth

Cigna (CI) reports strong Q2 financial results driven by Evernorth Health Services and Express Scripts' innovative programs.
Focus on affordability, access, and behavioral health services propels growth in U.S. employer business.
Challenges include navigating healthcare cost pressures and ensuring fair pricing negotiations.
Opportunities lie in biosimilar growth, sustainable revenue outlook, and strategic Medicare Advantage business sale.

Cigna reports robust Q3 earnings, eyes growth opportunities in 2025

Cigna's Q3 earnings call highlighted strong financial performance, strategic focus on shareholder value, and challenges in specialty drugs and cost trends. The company is optimistic about opportunities in 2025 and remains committed to delivering shareholder value through strategic initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cigna (CI) expands its plan offerings on the Affordable Care Act's insurance exchanges, branching out into additional counties across three states for 2022.

Cigna (CI) Expands Its Footprint in the ACA Marketplace

Cigna Corp said on Thursday it would now sell health insurance plans on online marketplaces created by the Affordable Care Act (ACA), popularly known as Obamacare, in three new U.S. states and 93 new counties.

Health Insurer Cigna to expand Obamacare to three new U.S. states

BLOOMFIELD, Conn., Aug. 26, 2021 /PRNewswire/ -- Global health services leader Cigna (NYSE: CI) is expanding its offerings to customers who access health coverage through the Affordable Care Act marketplace.

Cigna Expands, Enhances ACA Marketplace Plans to Increase Access to Quality Care in More Communities

UnitedHealth Group

The healthcare insurance industry is reasonably attractive at this time, but some companies have very different valuations.

A Tale Of Two Health Insurers

Cigna's (CI) board raises share buyback authorization in an effort to support prudent capital deployment.

Cigna (CI) Hikes Buyback Authorization, Boosts Shareholder Value

BLOOMFIELD, Conn., Aug. 25, 2021 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE:CI) announced today that David Cordani, president and chief executive officer, will present at the Morgan Stanley 19th Annual Global Healthcare Conference on September 14, 2021 through a virtual webcast.

Cigna Corporation Announces Appearance at the Morgan Stanley 19th Annual Global Healthcare Conference

Shares of Cigna Corp. CI, +0.10% rose 1.4% in premarket trading Tuesday, after the insurer announced a $2.0 billion accelerated stock repurchase (ASR) agreement with Morgan Stanley and J.P. Morgan Chase Bank.

Cigna stock rallies after setting $2 billion ASR

BLOOMFIELD, Conn., Aug. 24, 2021 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE: CI) will repurchase $2.0 billion of common stock through accelerated stock repurchase agreements (the "ASR Agreements") with each of Morgan Stanley & Co. LLC and JPMorgan Chase Bank, N.A.

Cigna Announces $2 Billion Accelerated Stock Repurchase Agreements

National Retail Properties

Redwood Trust

All the investment firms and banks that we follow here at 24/7 Wall St. keep a list for their institutional and retail clients of high-conviction stock picks.

5 Raymond James Analyst Favorite Stocks Look Safe and Pay Big, Dependable Dividends

Cigna has seen a material drop in share price since its second quarter earnings release.

Cigna's Mega-Drop Is Your Big Chance To Buy

Cigna Corp said on Wednesday it requires its employees working remotely to be fully vaccinated before entering any U.S. worksite from Sept. 7, as infections from the Delta variant of the coronavirus rise in the country.

Cigna requires employees returning to office to be fully vaccinated

BLOOMFIELD, Conn., Aug. 18, 2021 /PRNewswire/ -- With confirmed cases of COVID-19 on the rise in the United States, Cigna has established new requirements to help protect its workforce.

Cigna Protects Its Workforce by Requiring COVID-19 Vaccinations or Testing for Employees Entering U.S. Worksites

Many investors bought out Cigna's 11% drawdown in early August, making a few percent in profit.

Cigna: Buying The Dip Is Quite Risky

WALTHAM, Mass., Aug. 16, 2021 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA) and Cigna (NYSE: CI) announce an expansion of their national effort to improve health outcomes and lower the cost of care for people living with kidney failure, or end stage renal disease (ESRD).

Fresenius Medical Care North America and Cigna Expand Efforts to Help People Living with Kidney Failure

The stock price of Cigna, a health insurance and pharmacy services management company, reached its all-time high of $267 in May this year, but it has since seen lower levels. A recent sell-off in the stock has led to a 9% drop in its price over the last five trading days to levels of $209 currently.

Will Cigna Stock Rebound After A 9% Fall Last Week?

' Cigna StressWaves Test' powered by Ellipsis Health's advanced AI technology First and only stress analysis model to detect both acoustic and semantic patterns in voice Available free-of-charge with visual stress results in 90-seconds HONG KONG, Aug. 9, 2021 /PRNewswire/ -- Cigna International announces the launch of the Cigna StressWaves Test, a free online tool that analyses acoustic and semantic voice patterns to evaluate stress levels. The StressWaves Test was created in partnership with Ellipsis Health, a medical technology developer and leader in AI health and vocal biomarkers.

Cigna Launches World's First Voice-Activated Stress Test

Allstate

D.R. Horton

Nucor

Synchrony Financial

Tyson Foods

Textron

Most of my clients want medium-risk portfolios. A few tilt more to the conservative side.

Sane Portfolio Advanced 47% Last Year

AbbVie

Abbott Labs

Anthem

Bristol-Myers

Johnson & Johnson

Medtronic

Merck

PIMCO Corporate & Income Opportunity Fund

Cohen & Steers Reit And Preferred Income Fund Inc

abrdn Life Sciences Investors 

Thermo Fisher Scientific

A monthly income stream provides a lot of flexibility for the income investor. Monthly dividends makes DCA work even better.

3 Big Dividends, Paying Monthly, For Your Retirement Basea

Leading health plan stocks slumped Thursday after Cigna warned about mounting pandemic costs. Monitor these chart levels for buying opportunities.

Cigna (CI) Earnings Spook Healthcare Plan Stocks

Cigna Corporation (CI) CEO David Cordani on Q2 2021 Results - Earnings Call Transcript

Cigna's (CI) better-than-expected Q2 earnings benefit from better revenues, partly offset by higher medical cost.

Cigna (CI) Q2 Earnings Beat on Revenue Growth But Shares Fall

Cigna (CI) delivered earnings and revenue surprises of 5.65% and 4.46%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Cigna (CI) Q2 Earnings and Revenues Surpass Estimates

Shares of Cigna (NYSE:CI) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were down 9.81% year over year to $5.24, which beat the estimate of $4.96.

Cigna: Q2 Earnings Insights

Cigna Corp (NYSE: CI) reports Q2 total revenues of $43.1 billion, +9.8% Y/Y, ahead of the consensus of $41.31 billion. Q2 adjusted EPS reached $5.24 compared with $5.81 a year ago, beating the consensus of $4.96.

Cigna Strongly Beats On Q2 Earnings; Raises FY21 Sales Outlook, Expects Higher Unfavorable COVID-19 Impact

Cigna Corp. reported Thursday second-quarter profit and revenue that topped forecasts, amid strength in the health insurers pharmacy business, while growth in customer relationships slowed from the previous quarter. The stock fell 2.8% in premarket trading.

News for Cigna Stock (CI)